|
1.
|
|
13 p, 254.2 KB |
Patient-Related Benefits for Adults with Cochlear Implantation : A Multicultural Longitudinal Observational Study
/
Lenarz, Thomas (Medizinische Hochschule Hannover) ;
Muller, Lida (Tygerberg Hospital) ;
Czerniejewska-Wolska, Hanna (Poznań University of Medical Sciences) ;
Varela, Hector Vallés (Hospital Clínico Universitario "Lozano Blesa" de Zaragoza) ;
Orús Dotú, César (Institut d'Investigació Biomèdica Sant Pau) ;
Durko, Marcin (Barlicki University Hospital) ;
Irujo, Alicia Huarte (Clinica Universitaria de Navarra) ;
Piszczatowski, Bartosz (Medical University of Bialystok) ;
Zadrożniak, Marek (Medical University of Lublin) ;
Irwin, Colin (Cochlear AG) ;
Graham, Petra L. (Macquarie University) ;
Wyss, Josie (Cochlear AG) ;
Universitat Autònoma de Barcelona
To assess subjectively perceived, real-world benefits longitudinally for unilateral cochlear implant (CI) recipients in a multinational population treated routinely. To identify possible predictors of self-reported benefits. [...]
2017 -  10.1159/000477533
Audiology and Neurotology, Vol. 22 Núm. 2 (january 2017) , p. 61-73
|
|
|
2.
|
|
8 p, 594.7 KB |
The Diabetes Unmet Need with Basal Insulin Evaluation (DUNE) study in type 2 diabetes : Achieving HbA1c targets with basal insulin in a real-world setting
/
Meneghini, Luigi F. (Parkland Health & Hospital System) ;
Mauricio Puente, Dídac (Institut d'Investigació Biomèdica Sant Pau) ;
Orsi, Emanuela (Fondazione Ca' Granda IRCCS) ;
Lalic, Nebojsa M. (University of Belgrade) ;
Cali, Anna M.G. (Sanofi) ;
Westerbacka, Jukka (Sanofi) ;
Stella, Peter (Sanofi) ;
Candelas, Christophe (Sanofi) ;
Pilorget, Valerie (Sanofi) ;
Perfetti, Riccardo (Sanofi) ;
Khunti, Kamlesh (University of Leicester) ;
Universitat Autònoma de Barcelona
To describe in a real-world setting the achievement of physician-selected individualized HbA1c targets in individuals with type 2 diabetes, newly or recently initiated with basal insulin, and the association of hypoglycaemia with target achievement. [...]
2019 - 10.1111/dom.13673
Diabetes, Obesity and Metabolism, Vol. 21 Núm. 6 (june 2019) , p. 1429-1436
|
|
|
3.
|
|
11 p, 284.2 KB |
Prediabetes is independently associated with subclinical carotid atherosclerosis : An observational study in a non-urban mediterranean population
/
Vilanova, Maria Belén (Universitat de Lleida) ;
Franch-Nadal, Josep (Institut Universitari d'Investigació en Atenció Primària Jordi Gol) ;
Falguera, Mireia (Institut Català de la Salut) ;
Marsal, Josep Ramon (Hospital Universitari Vall d'Hebron) ;
Canivell, S. (Institut Català de la Salut) ;
Rubinat, Esther (Institut de Recerca Biomèdica de Lleida) ;
Miró, Neus (Institut Català de la Salut) ;
Molló, Àngels (Institut Català de la Salut) ;
Mata-Cases, Manel (Institut Català de la Salut) ;
Gratacòs, Mònica (Institut Universitari d'Investigació en Atenció Primària Jordi Gol) ;
Castelblanco, Esmeralda (Institut d'Investigació Biomèdica Sant Pau) ;
Mauricio Puente, Dídac (Institut d'Investigació Biomèdica Sant Pau) ;
Universitat Autònoma de Barcelona
This was a prospective, observational study to compare the burden of subclinical atherosclerosis as measured by carotid ultrasonography in a cohort of subjects with prediabetes vs. subjects with normal glucose tolerance (NGT) from a non-urban Mediterranean population. [...]
2020 - 10.3390/jcm9072139
Journal of clinical medicine, Vol. 9 Núm. 7 (july 2020) , p. 1-11
|
|
|
4.
|
|
13 p, 473.7 KB |
Effects of a Digital Patient Empowerment and Communication Tool on Metabolic Control in People With Type 2 Diabetes : The DeMpower Multicenter Ambispective Study
/
Orozco-Beltrán, Domingo (Universidad Miguel Hernández de Elche. Departamento de Medicina Clínica) ;
Morales, Cristobal Jesus (Department of Endocrinology. Hospital Vithas) ;
Artola, Sara (Centro de Salud José Marvá (Madrid)) ;
Brotons, Carlos (Institut d'Investigació Biomèdica Sant Pau) ;
Carrascosa, Sara (El Campello Primary Health Care Center) ;
González, Cintia (Institut d'Investigació Biomèdica Sant Pau) ;
Baro Pato, Óscar (Galapagar Primary Care Center. RedGDPs Foundation) ;
Aliaga, Alberto (Department of Endocrinology. Clínica New Technologies in Diabetes and Endocrinology) ;
Ferreira de Campos, Karine (Medical Affairs Department. MSD Spain) ;
Villarejo, Maria (Medical Affairs Department. MSD Spain) ;
Hurtado, Carlos (Medical Affairs Department. MSD Spain) ;
Álvarez-Ortega, Carolina (Medical Affairs Department. MSD Spain) ;
Gómez-García, Anton (Medical Affairs Department. MSD Spain) ;
Cedenilla, Marta (Medical Affairs Department. MSD Spain) ;
Fernández, Gonzalo (Medical Affairs Department. MSD Spain)
Background: Diabetes is a major health care problem, reaching epidemic numbers worldwide. Reducing hemoglobin A (HbA) levels to recommended targets is associated with a marked decrease in the risk of type 2 diabetes mellitus (T2DM)-related complications. [...]
2022 - 10.2196/40377
JMIR Diabetes, Vol. 7 Núm. 4 (january 2022) , p. e40377
|
|
|
5.
|
|
11 p, 4.3 MB |
Trends in the Degree of Control and Treatment of Cardiovascular Risk Factors in People With Type 2 Diabetes in a Primary Care Setting in Catalonia During 2007-2018
/
Mata-Cases, Manel (Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas) ;
Vlacho, Bogdan (IDIAP Jordi Gol. Grup de Recerca Epidemiològica en Diabetis des de l'Atenció Primària. Unitat de Suport a la Recerca Barcelona) ;
Real, Jordi (Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas) ;
Puig Treserra, Ramon (Institut Universitari d'Investigació en Atenció Primària Jordi Gol) ;
Bundó, Magdalena (Institut Català de la Salut) ;
Franch-Nadal, Josep (Institut Català de la Salut) ;
Mauricio Puente, Dídac (Institut d'Investigació Biomèdica Sant Pau)
Objective: To assess the trends in cardiovascular risk factor control and drug therapy from 2007 to 2018 in subjects with type 2 diabetes mellitus (T2DM). Materials and Methods: Cross-sectional analysis using yearly clinical data and treatment obtained from the SIDIAP database. [...]
2021 - 10.3389/fendo.2021.810757
Frontiers in Endocrinology, Vol. 12 (october 2021) , p. 810757
|
|
|
6.
|
|
20 p, 1.2 MB |
Real-World Treatment Patterns and Clinical Outcomes of Baricitinib in Rheumatoid Arthritis Patients in Spain : Results of a Multicenter, Observational Study in Routine Clinical Practice (The ORBIT-RA Study)
/
Hernández-Cruz, Blanca (Hospital Universitario Virgen Macarena (Sevilla, Andalusia)) ;
Rosas, José (Hospital Marina Baixa. Servei de Reumatologia) ;
Díaz Torne, César (Institut d'Investigació Biomèdica Sant Pau) ;
Belzunegui, Joaquín (Hospital Universitario Donostia. Servicio de Reumatología) ;
García-Vicuña, Rosario (Hospital Universitario de La Princesa. Servicio de Reumatología. IIS-IP) ;
Inciarte-Mundo, José (Hospital Clínic i Provincial de Barcelona) ;
Pons, Ana (Hospital Marina Baixa. Servei de Reumatologia) ;
Millán, Ana M. (Hospital de la Santa Creu i Sant Pau (Barcelona, Catalunya)) ;
Jeria-Navarro, Sicylle (Hospital de la Santa Creu i Sant Pau (Barcelona, Catalunya)) ;
Valero, Jesús A. (Hospital Universitario Donostia. Servicio de Reumatología) ;
García-Castañeda, Noelia (Hospital Universitario de La Princesa. Servicio de Reumatología. IIS-IP) ;
Valero Martínez, Cristina (Hospital Universitario de La Princesa. Servicio de Reumatología. IIS-IP) ;
Llorente Cubas, Irene (Hospital Universitario de La Princesa. Servicio de Reumatología. IIS-IP) ;
Calvo, Alberto (Hospital Universitario de La Princesa. Servicio de Reumatología. IIS-IP) ;
Díaz-Cerezo, Silvia (Lilly Spain. Medical Department) ;
Núñez, Mercedes (Lilly Spain. Medical Department)
Introduction: Baricitinib is an oral Janus kinase (JAK)1/JAK2 inhibitor approved to treat rheumatoid arthritis (RA). This study aimed to investigate patients' characteristics, prescription patterns, effectiveness, and treatment persistence in patients receiving baricitinib in real-world practice in Spain. [...]
2022 - 10.1007/s40744-021-00423-8
Rheumatology and Therapy, Vol. 9 Núm. 2 (april 2022) , p. 589-608
|
|
|
7.
|
|
8 p, 1.1 MB |
Analysis of the Adherence and Safety of Second Oral Glucose-Lowering Therapy in Routine Practice From the Mediterranean Area : A Retrospective Cohort Study
/
Vlacho, Bogdan (Institut d'Investigació Biomèdica Sant Pau) ;
Mata-Cases, M. (Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas) ;
Mundet-Tudurí, Xavier (Universitat Autònoma de Barcelona. Departament de Medicina) ;
Vallès-Callol, J.A. (Institut Universitari d'Investigació en Atenció Primària Jordi Gol) ;
Real, J. (Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas) ;
Farre, Magi (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Cos Claramunt, Francesc Xavier (Institut Català de la Salut) ;
Khunti, K. (Diabetes Research Centre. College of Life Sciences. University of Leicester) ;
Mauricio Puente, Dídac (Institut d'Investigació Biomèdica Sant Pau) ;
Franch-Nadal, J. (Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas)
The aims of our study was compare adherence measured by the medical possession ratio (MPR), time until discontinuation and describe adverse events after adding a DPP-4i, SGLT-2i, or sulfonylureas (SU) to metformin in a primary care population with insufficient glycemic control. [...]
2021 - 10.3389/fendo.2021.708372
Frontiers in Endocrinology, Vol. 12 (July 2021) , p. 708372
|
|
|
8.
|
|
17 p, 890.5 KB |
Glucagon-Like Peptide-1 Receptor Agonists in Patients with Type 2 Diabetes : Prescription According to Reimbursement Constraints and Guideline Recommendations in Catalonia
/
Franch-Nadal, Josep (Institut Català de la Salut) ;
Mata-Cases, Manel (Institut Català de la Salut) ;
Ortega, Emilio (Centro de Investigación Biomédica en Red de Fisiopatología de la Obesidad y Nutrición) ;
Real, Jordi (Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas) ;
Gratacòs, Mònica (Institut Universitari d'Investigació en Atenció Primària Jordi Gol) ;
Vlacho, Bogdan (Institut Universitari d'Investigació en Atenció Primària Jordi Gol) ;
Vallés, Joan Antoni (Institut Català de la Salut) ;
Mauricio Puente, Dídac (Institut d'Investigació Biomèdica Sant Pau) ;
Universitat Autònoma de Barcelona
To assess the clinical characteristics, the prescription pattern of GLP-1 receptor agonists (GLP-1RA) users, and HbA1c and weight change, we retrospectively assessed patients with type 2 diabetes by initiating GLP-1RA as an add-on to the standard of care in Catalonia. [...]
2019 - 10.3390/jcm8091389
Journal of clinical medicine, Vol. 8 (september 2019)
|
|
|
9.
|
|
10 p, 2.0 MB |
The Association Between Diabetes Mellitus and Risk of Sarcopenia : Accumulated Evidences From Observational Studies
/
Qiao, Yu-Shun (Beijing Tongren Hospital, Capital Medical University) ;
Chai, Yin-He (Beijing Tongren Hospital) ;
Gong, Hong-Jian (Beijing Tongren Hospital) ;
Zhuldyz, Zhiyessova (Beijing Tongren Hospital) ;
Stehouwer, Coen D. A. (Maastricht University Medical Center) ;
Zhou, Jian-Bo (Beijing Tongren Hospital) ;
Simó Canonge, Rafael (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Universitat Autònoma de Barcelona
We performed a meta-analysis of observational studies to evaluate the association between the presence of sarcopenia and HbA1c, prediabetes, diabetes and diabetic complications. The PubMed, Embase, Cochrane and Web of Science databases were searched from inception to May 2021. [...]
2021 - 10.3389/fendo.2021.782391
Frontiers in Endocrinology, Vol. 12 (december 2021)
|
|
|
10.
|
|
12 p, 370.9 KB |
A Cross-National Comparison of Myalgic Encephalomyelitis and Chronic Fatigue Syndrome at Tertiary Care Settings from the US and Spain
/
Bhatia, Shaun (DePaul University) ;
Olczyk, Nicole (DePaul University) ;
Jason, Leonard A. (DePaul University) ;
Alegre Martín, José (Hospital Universitari Vall d'Hebron) ;
Fuentes Llanos, Judith (Hospital Universitari Vall d'Hebron) ;
Castro-Marrero, Jesús (Hospital Universitari Vall d'Hebron) ;
Universitat Autònoma de Barcelona
Cross-national comparative studies are useful for describing the unique characteristics of complex illnesses, and can reveal culture-specific traits of disease frequency/severity and healthcare. Though myalgic encephalomyelitis (ME) and chronic fatigue syndrome (CFS) are debilitating conditions found all over the world, few studies have examined their characteristics across different countries. [...]
2019 - 10.20448/801.51.104.115
American journal of social sciences and humanities, Vol. 5 (december 2019) , p. 104-115
|
|
guest ::
email alert
or subscribe to the 
RSS feed.
